BN
Brookfield Corporation
BN has a slight edge over MS overall, supported by stronger valuation.
MS
Morgan Stanley
MS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $41.64 | — |
| Cheap | 20x | $10.94 | -74% |
| Fair | 71x | $39.79 | -4.4% |
| Current | 75x | $41.64 | — |
| Expensive | 130x | $72.77 | +75% |
Historical ranges are pointers, not guarantees.
BN's PE is in its fair range at 75x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over BN in the historical PE scenario, which offers more potential upside but is not a forecast.
BN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for BN, with profitability holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.22 | +475% |
| Q2 2026 | $0.56 | +87% |
| Q1 2026 | $0.52 | +160% |
| Q4 2025 | $0.49 | +133% |
| Q3 2025 | $0.36 | +13% |
| Q2 2025 | $0.30 | -21% |
| Q1 2025 | $0.20 | -50% |
| Q4 2024 | $0.21 | -49% |
| Q3 2024 | $0.32 | +$0.34 |
BN's earnings per share have fallen from their peak: $0.56 over the past year, against $1.66 in late 2019.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BN on earnings, with more consistent year-over-year improvement.
BN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3B | +6.6% |
| Q1 2026 | $18.4B | +2.5% |
| Q4 2025 | $21.2B | +9% |
| Q3 2025 | $18.9B | -8.3% |
| Q2 2025 | $18.1B | -22% |
| Q1 2025 | $17.9B | -22% |
| Q4 2024 | $19.4B | -21% |
| Q3 2024 | $20.6B | -16% |
BN's revenue is recovering but still below its 2023 peak: $19.3B last quarter, up 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 24% | +1.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 42% | +16 points |
| Q3 2025 | 23% | -2.9 points |
| Q2 2025 | 23% | +6.1 points |
| Q1 2025 | 25% | +8.2 points |
| Q4 2024 | 26% | +9.9 points |
| Q3 2024 | 26% | +12 points |
BN's operating margin was 24% last quarter, up 1.3 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BN on profitability, with a higher operating margin.
BN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8B | -$1B |
| Q1 2026 | -$5.6B | -$4.5B |
| Q4 2025 | $0 | +$24.5M |
| Q3 2025 | -$919.1M | -238% |
| Q2 2025 | -$750M | +$943.6M |
| Q1 2025 | -$1.1B | +$1.5B |
| Q4 2024 | -$24.5M | +$1.2B |
| Q3 2024 | $665.5M | -48% |
BN's free cash flow was −$8.3B over the past year, against −$1.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like BN.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +8M shares |
| 3 years | 0% | -600K shares |
| 5 years | +1.8% | +42M shares |
| Available history | +7.3% | +162M shares |
BN has 2.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $109.6M |
| Q1 2026 | $431.9M |
| Q4 2025 | — |
| Q3 2025 | $35.4M |
| Q2 2025 | $293.6M |
| Q1 2025 | $567.3M |
| Q4 2024 | $136.3M |
| Q3 2024 | $79.4M |
BN spent $577M buying back its own shares over the past year, down 46% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BN on shareholder dilution, with a more favorable share count trend.
BN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.5x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 9.0x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 7.5x | High |
| Q3 2024 | 7.3x | High |
BN has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 51.5 | Neutral |
BN's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BN PE vs Financial Services Sector
| Metric | BN | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 13x | 473% above |
| PE % | 54 | 63 | 9 pts below |
BN is trading at 75x earnings, a 473% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over BN on valuation relative to its sector.
BN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 8.2% above |
| 20 week MA | $40.5 | 2.8% above |
| 50 week MA | $43.0 | 3.1% below |
| 100 week MA | $41.8 | 0.4% below |
| 200 week MA | $34.2 | 22% above |
BN's trend is mixed: it's above three of its five weekly moving averages, and 22% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.9 | +5.6% |
| 2021 | $21.9 | $32.3 | +48% |
| 2022 | $32.3 | $21.2 | -35% |
| 2023 | $21.2 | $26.8 | +26% |
| 2024 | $26.8 | $38.1 | +43% |
| 2025 | $38.1 | $46.7 | +23% |
| 2026 YTD | $46.7 | $41.6 | -11% |
BN has finished higher in five of the last six years. It's down 11% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BN on returns for 2026, with the stronger performance.